Suchergebnisse - "Laing, Adam G."

PubPharm (20)

1

Innate TCRβ-chain engagement drives human T cells toward distinct memory-like effector phenotypes with immunotherapeutic potentials

enthalten in: Science advances | 2023

von Vantourout, P. | Eum, J. | Conde Poole, M. | +13

2

Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority guidelines

enthalten in: bioRxiv.org | 2023

von Monin-Aldama, L. | Laing, A. | Muñoz-Ruiz, M. | +38

3

Prolidase Deficiency Causes Spontaneous T Cell Activation and Lupus-like Autoimmunity

enthalten in: Journal of immunology (Baltimore, Md. : 1950) | 2023

von Hodgson, R. | Crockford, T. | Bhandari, A. | +13

4

COVID-19 : Using high-throughput flow cytometry to dissect clinical heterogeneity

enthalten in: Cytometry. Part A : the journal of the International Society for Analytical Cytology | 2023

von Del Molino Del Barrio, I. | Hayday, T. | Laing, A. | +2

5

COVID‐19 : Using high‐throughput flow cytometry to dissect clinical heterogeneity

enthalten in: Cytometry Part B: Clinical Cytometry | 2023

von del Molino del Barrio, I. | Hayday, T. | Laing, A. | +2

6

A consensus Covid-19 immune signature combines immuno-protection with discrete sepsis-like traits associated with poor prognosis

enthalten in: bioRxiv.org | 2022

von Laing, A. | Lorenc, A. | Del Molino Del Barrio, I. | +45

7

Global patterns of antigen receptor repertoire disruption across adaptive immune compartments in COVID-19

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2022

von Joseph, M. | Wu, Y. | Dannebaum, R. | +38

8

Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer : interim analysis of a prospective observational study

enthalten in: The Lancet. Oncology | 2021

von Monin, L. | Laing, A. | Muñoz-Ruiz, M. | +41

CommentIn: Lancet Oncol. 2021 Jun;22(6):738-739. - PMID 34087120

9

Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant

enthalten in: Immunity | 2021

von Graham, C. | Seow, J. | Huettner, I. | +26

UpdateOf: bioRxiv. 2021 Feb 03;:. - PMID 33564766

10

Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer Patients

enthalten in: Cancer cell | 2021

von Abdul-Jawad, S. | Baù, L. | Alaguthurai, T. | +48